Skip to content
healthcare.dev

Qbrexza

NDC 69489-411, glycopyrronium, cloth, from Journey Medical Corporation.

Product NDC
69489-411
Status
Listed
Labeler
Journey Medical Corporation
Dosage form
CLOTH
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210361
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69489-411 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCOPYRRONIUM TOSYLATE2.4 g/100g

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
69489-411-05694890411055 POUCH in 1 CARTON (69489-411-05) / 2.8 g in 1 POUCH (69489-411-51)
69489-411-306948904113030 POUCH in 1 CARTON (69489-411-30) / 2.8 g in 1 POUCH (69489-411-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5b372650-e56e-47a5-93e2-c0c292017059

Use it

Look up 69489-411 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69489-411 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69489-411. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.